TY - JOUR
T1 - Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats
AU - Fathi Moghaddam, Hadi
AU - Ardestani, Mehdi Shafiee
AU - Saffari, Mostafa
AU - Navidpour, Latifeh
AU - Shafiee, Abbas
AU - Rahmim, Arman
PY - 2008/10
Y1 - 2008/10
N2 - In the present work, we studied the effect of the selective cyclooxygenase-2 (COX-2) inhibitors, compound 11 g, celecoxib and selective COX-1 inhibitor SC-560 (intraperitoneally and acutely) on striatal glutamatergic and dopaminergic neurotransmission in normal and substantia nigra pars compacta (SNc)-lesioned rats using the microdialysis technique. We also investigated the effect of acute COX inhibition on the damaged SNc neurons. Our results indicate a significant increase in dopaminergic neurotransmission and a decrease in glutamatergic neurotransmission (P < 0.05) only after selective COX-2 inhibition in the striatum of normal and hemiparkinsonian rats. Nonetheless, neither COX-1 nor COX-2 inhibitors showed any improvement in the damaged SNc neurons.
AB - In the present work, we studied the effect of the selective cyclooxygenase-2 (COX-2) inhibitors, compound 11 g, celecoxib and selective COX-1 inhibitor SC-560 (intraperitoneally and acutely) on striatal glutamatergic and dopaminergic neurotransmission in normal and substantia nigra pars compacta (SNc)-lesioned rats using the microdialysis technique. We also investigated the effect of acute COX inhibition on the damaged SNc neurons. Our results indicate a significant increase in dopaminergic neurotransmission and a decrease in glutamatergic neurotransmission (P < 0.05) only after selective COX-2 inhibition in the striatum of normal and hemiparkinsonian rats. Nonetheless, neither COX-1 nor COX-2 inhibitors showed any improvement in the damaged SNc neurons.
UR - http://www.scopus.com/inward/record.url?scp=52049085762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=52049085762&partnerID=8YFLogxK
U2 - 10.1111/j.1742-7843.2008.00295.x
DO - 10.1111/j.1742-7843.2008.00295.x
M3 - Article
C2 - 18764909
AN - SCOPUS:52049085762
SN - 1742-7835
VL - 103
SP - 293
EP - 296
JO - Basic and Clinical Pharmacology and Toxicology
JF - Basic and Clinical Pharmacology and Toxicology
IS - 4
ER -